Princeton-based provider of regulatory and ethical review services for clinical research WIRB-Copernicus Group announced today it has appointed Dr. Lindsay McNair chief clinical research officer. McNair will be responsible for developing strategic partnerships and will oversee WCG's Consulting Division supporting pharmaceutical and biotechnology companies.
According to the announcement, for more than 13 years, Dr. McNair has been actively involved with institutional review boards. Prior to joining WCG, she acted as a consultant to pharmaceutical and biotechnology companies, providing medical guidance on clinical development strategies and designs for new drug studies, as well as handling medical oversight of all phases of clinical trials.
Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.View Comment Policy